MedTrace Logo

Cozaar XQ Re-examination Study (MK-0954-349)

NCT01041807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 669

Last updated 2022-02-15

No results posted yet for this study

Summary

This survey is conducted for preparing application material for re-examination under the Pharmaceutical Affairs Law and its Enforcement Regulation; its aim is to reconfirm the clinical usefulness of COZAAR XQ through collecting the safety and efficacy information according to the Re-examination Regulation for New Drugs.

Conditions

Interventions

DRUG

amlodipine/losartan

amlodipine/losartan (COZAAR XQ) prescribed according to the current local label

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01041807 on ClinicalTrials.gov